Does the EQ-5D measure quality of life in schizophrenia?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Does the EQ-5D measure quality of life in schizophrenia? / Halling Hastrup, Lene; Nordentoft, Merete; Hjorthoej, Carsten; Gyrd-Hansen, Dorte.
I: Journal of Mental Health Policy and Economics (Print Edition), Bind 14, Nr. 4, 2011, s. 187-96.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Does the EQ-5D measure quality of life in schizophrenia?
AU - Halling Hastrup, Lene
AU - Nordentoft, Merete
AU - Hjorthoej, Carsten
AU - Gyrd-Hansen, Dorte
PY - 2011
Y1 - 2011
N2 - Most health economic evaluations in mental care include outcome measures aimed at specific aspects of health, like symptom improvement, functional improvement and quality of life instead of generic preference based outcome measures. The health economic guidelines (NICE) recommend to include a generic preference based outcome measure, like EQ-5D, in health economic evaluations in order to allow for comparisons of health related quality of life of patient groups across different diseases, providing information particular useful to support health policy decisions and cost-effectiveness analysis. Although the EQ-5D is by far the most widespread outcome measure within the context of economic evaluations, its validity in psychiatric populations has not yet been established unambiguously. An increasing number of articles have tested the validity of the EQ-5D in comparisons with clinical measures in mental health, but only few studies have addressed the correlation between the EQ-5D and a condition-specific quality of life measure in mental health.
AB - Most health economic evaluations in mental care include outcome measures aimed at specific aspects of health, like symptom improvement, functional improvement and quality of life instead of generic preference based outcome measures. The health economic guidelines (NICE) recommend to include a generic preference based outcome measure, like EQ-5D, in health economic evaluations in order to allow for comparisons of health related quality of life of patient groups across different diseases, providing information particular useful to support health policy decisions and cost-effectiveness analysis. Although the EQ-5D is by far the most widespread outcome measure within the context of economic evaluations, its validity in psychiatric populations has not yet been established unambiguously. An increasing number of articles have tested the validity of the EQ-5D in comparisons with clinical measures in mental health, but only few studies have addressed the correlation between the EQ-5D and a condition-specific quality of life measure in mental health.
M3 - Journal article
VL - 14
SP - 187
EP - 196
JO - Journal of Mental Health Policy and Economics
JF - Journal of Mental Health Policy and Economics
SN - 1091-4358
IS - 4
ER -
ID: 40183504